Bioprostheses are prone to structural valve degeneration, resulting in limited long-term
durability. A significant challenge when comparing the durability of different types of …

In recent times, there has been a considerable increase in the use of aortic bioprostheses
(vs. mechanical prostheses) for treating aortic valve disease, and this tendency is likely to …

Background Subclinical leaflet thrombosis of bioprosthetic aortic valves after transcatheter
valve replacement (TAVR) and surgical aortic valve replacement (SAVR) has been found …

The implantation of bioprosthetic heart valves (BHVs) is increasingly becoming the treatment
of choice in patients requiring heart valve replacement surgery. Unlike mechanical heart …

Bioprosthetic valve (BPV) thrombosis is considered a relatively rare clinical entity. Yet a
more recent analysis involving a more systematic echocardiographic follow-up, the advent of …

Transcatheter aortic valve implantation (TAVI) has become the standard of care for
inoperable patients, and the preferred treatment option for high-risk patients with severe …

The current clinical solutions, including mechanical and bioprosthetic valves for valvular
heart diseases, are plagued by coagulation, calcification, nondurability, and the inability to …

Transcatheter aortic valve replacement (TAVR) has emerged as an effective alternative to
conventional surgical valve replacement in high-risk patients afflicted by severe aortic …

Purpose Transcatheter aortic valve replacement (TAVR) is a minimally invasive treatment for
high-risk patients with aortic diseases. Despite its increasing use, many influential factors …

Objectives: The aim of this study was to assess the commissural alignment between
bioprosthetic and native aortic valve leaflets following surgical aortic valve replacement …